Sunitinib in the Pediatric Clinical Practice

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F19%3A00108972" target="_blank" >RIV/00216224:14110/19:00108972 - isvavai.cz</a>
Result on the web
<a href="https://novapublishers.com/shop/sunitinib-mechanisms-interactions-and-side-effects/" target="_blank" >https://novapublishers.com/shop/sunitinib-mechanisms-interactions-and-side-effects/</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Sunitinib in the Pediatric Clinical Practice
Original language description
The aim of the chapter is to summarize the published results of clinical research focused on the use of sunitinib in pediatric oncology and to supplement it with the experience from the authors’ clinical practice. Suggestions appearing in case reports and clinical trials indicate that sunitinib may be a valuable drug also in pediatric clinical oncology. More attention should be paid to the selection of the most suitable indications, patients, and doses to balance the efficacy and safety in children with malignant diseases.
Czech name
—
Czech description
—

Project
<a href="/en/project/LM2015090" target="_blank" >LM2015090: Czech National Node to the European Clinical Research Infrastructure Network</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)